BNP/CALL/ALCON AG/75/0.1/20.09.24 Stock

Warrant

DE000PN8TGX7

Market Closed - Börse Stuttgart 04:15:48 2024-06-14 EDT
0.82 EUR -13.68% Intraday chart for BNP/CALL/ALCON AG/75/0.1/20.09.24
Current month+3.80%
1 month-2.38%
Date Price Change
24-06-14 0.82 -13.68%
24-06-13 0.95 +14.46%
24-06-12 0.83 -4.60%
24-06-11 0.87 -3.33%
24-06-10 0.9 +2.27%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 04:15 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ALCON INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN8TGX
ISINDE000PN8TGX7
Date issued 2023-09-26
Strike 75 CHF
Maturity 2024-09-20 (97 Days)
Parity 10 : 1
Emission price 0.52
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.97
Lowest since issue 0.15
Spread 0.01
Spread %1.25%

Company Profile

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Sector
-
More about the company

Ratings for Alcon Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Alcon Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
90.26 USD
Average target price
93.45 USD
Spread / Average Target
+3.54%
Consensus